Docosahexaneoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathways
about
Nutrigenomics and Beef Quality: A Review about LipogenesisOmega-3 fatty acids for the treatment of non-alcoholic fatty liver diseaseMechanisms of gene regulation by fatty acidsA metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- miceRegulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonistFluorescent n-3 and n-6 very long chain polyunsaturated fatty acids: three-photon imaging in living cells expressing liver fatty acid-binding proteinOxysterols and their cellular effectors.Regulation of hepatic gene expression by saturated fatty acids.Role of fatty acid elongases in determination of de novo synthesized monounsaturated fatty acid speciesPhysiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice.Flaxseed oil prevents trans-10, cis-12-conjugated linoleic acid-induced insulin resistance in mice.The diverse functions of oxysterol-binding proteinsFatty acid signaling: the new function of intracellular lipases.Botanical oils enriched in n-6 and n-3 FADS2 products are equally effective in preventing atherosclerosis and fatty liverActivation of hepatic lipase expression by oleic acid: possible involvement of USF1.Regulation of SREBPs by Sphingomyelin in Adipocytes via a Caveolin and Ras-ERK-MAPK-CREB Signaling Pathway(n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.Polyunsaturated fatty acids: From diet to binding to ppars and other nuclear receptors.Omega-3 fatty acid supplementation and cardiovascular disease.Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese miceFish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.Anticancer Properties of PPARalpha-Effects on Cellular Metabolism and Inflammation.Docosahexaenoic acid (DHA) and hepatic gene transcriptionElevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate compositionDeletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in miceN-3 polyunsaturated fatty acid regulation of hepatic gene transcription.Polyunsaturated fatty acyl-coenzyme As are inhibitors of cholesterol biosynthesis in zebrafish and mice.Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.Docosahexaenoic acid enhances hepatic serum amyloid A expression via protein kinase A-dependent mechanism.N-3 polyunsaturated fatty acids suppress insulin-induced SREBP-1c transcription via reduced trans-activating capacity of LXRalpha.Fatty acid-regulated transcription factors in the liver.Lipid metabolism-related gene expression pattern of Atlantic bluefin tuna (Thunnus thynnus L.) larvae fed on live prey.Regulation of gene transcription by fatty acids.Exercise and Omega-3 Polyunsaturated Fatty Acid Supplementation for the Treatment of Hepatic Steatosis in Hyperphagic OLETF RatsEicosapentaenoic acid down-regulates expression of the selenoprotein P gene by inhibiting SREBP-1c protein independently of the AMP-activated protein kinase pathway in H4IIEC3 hepatocytes.Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.Polyunsaturated fatty acids selectively suppress sterol regulatory element-binding protein-1 through proteolytic processing and autoloop regulatory circuit.Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver.
P2860
Q26746261-97A99119-CEF0-4C83-9941-92ED504B8767Q26825517-CED74E34-609E-45B8-A199-42504F548CA3Q26863658-E0EC2683-A841-4323-8535-3E6537458743Q27339224-D79FDAE4-DA1C-4FFB-9255-2A92AE46F918Q28565706-3BF6AF1F-431B-4ED6-B947-9295D3773771Q33552039-C2B5BE94-4E42-49E7-9EB6-0B5B17317EB8Q33649595-4E692020-DD86-43CA-9564-6B99E0B6EFA9Q33816670-986409D1-D4F4-4578-8464-EF86602F2148Q33901997-A46FF06F-64FC-46F2-ABAB-CFDB6ED50500Q34066977-C530715B-2960-49AA-9F18-2E237994E988Q34760318-B7B42B30-70A9-4355-989C-1BB9FBE54427Q34810136-618D6AC7-E420-4C5E-AFA6-B70AC4C8AA41Q34990521-6E23ED4A-1165-4B23-AC0D-DEE272DEDF44Q35139141-82EAC414-D3BF-44DA-BD4E-48C2F4322E50Q35642914-A4BE244B-FD35-4144-89C4-87E64869A58AQ35670791-AF7C3487-15BB-4B53-95E3-722049C493DFQ35731006-4E02B0A3-7A50-4546-A152-47ECC2CF3762Q35753222-4563D645-E094-4801-9128-2929DBD65A78Q36096333-D69A113F-AFC9-43DA-B9EF-EDED02535730Q36267294-73D4157E-C76B-4DE4-9F87-2315103EEB53Q36387184-2654D6AE-B3BF-4058-9F7F-6BAB5FFB1A54Q36462135-7D9D0835-9B60-4FFF-A80C-49EF5B8BDF92Q36530010-C0A06499-66D5-4A9D-B3C1-A1913BCD4A84Q36675898-CFA4C543-0731-4101-9431-2B7AFAC4DA08Q36725271-7F424FE6-8CAF-48D7-A26D-A3C8C9B1F5FBQ36727408-78AD2F06-FE03-4E08-834A-D26570D47F63Q37089101-E2B60EAD-C6CC-4FFD-B86E-0D969C8A3509Q37156302-29FC5EB9-3C17-411E-86CA-6A8BD714408FQ37287426-91522B10-AFF3-49F5-B67D-743A6B41AC69Q37393336-683F5A2D-23FA-460D-9267-87BB632347F1Q37431895-F4537C53-6E62-4BB8-A879-58C8CCE98984Q37439291-1D0515B9-4CE1-45DB-8DBE-07A26C57896DQ37613511-0B2CE1B7-22DF-4074-AA4C-30A16304CA58Q37731005-56B1F887-16C0-41D7-8958-F9EBEF8C449DQ37996638-FCBA437C-73A2-47F2-9317-6E68365773CCQ38384889-9CF82265-A450-4622-9853-143C3D48BB24Q38705146-59CC40C1-4188-4713-8A6C-BBA08B5D3523Q39445103-803F0070-AA9B-4BB8-9DD9-88D4A9025523Q39741460-9ABB97DC-5F66-4CBF-8CBB-567A3393BD8BQ39791105-6FA51DDE-F269-4E09-BC23-22CF0EA4FC9D
P2860
Docosahexaneoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathways
description
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Januar 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/01/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/01/01)
@nl
наукова стаття, опублікована в січні 2006
@uk
مقالة علمية (نشرت عام 2006)
@ar
name
Docosahexaneoic acid (22:6,n-3 ...... proteasome-dependent pathways
@ast
Docosahexaneoic acid (22:6,n-3 ...... proteasome-dependent pathways
@en
Docosahexaneoic acid (22:6,n-3 ...... proteasome-dependent pathways
@nl
type
label
Docosahexaneoic acid (22:6,n-3 ...... proteasome-dependent pathways
@ast
Docosahexaneoic acid (22:6,n-3 ...... proteasome-dependent pathways
@en
Docosahexaneoic acid (22:6,n-3 ...... proteasome-dependent pathways
@nl
prefLabel
Docosahexaneoic acid (22:6,n-3 ...... proteasome-dependent pathways
@ast
Docosahexaneoic acid (22:6,n-3 ...... proteasome-dependent pathways
@en
Docosahexaneoic acid (22:6,n-3 ...... proteasome-dependent pathways
@nl
P2093
P2860
P3181
P1476
Docosahexaneoic acid (22:6,n-3 ...... proteasome-dependent pathways
@en
P2093
Barbara Christian
Daniela Botolin
Donald B. Jump
P2860
P304
P3181
P356
10.1194/JLR.M500365-JLR200
P577
2006-01-01T00:00:00Z